Skip to content
Search

Latest Stories

English pharmacy – Hope for the future

Facts about the current state of English pharmacies
Adele West-Curran, Chief Operating Officer, RWA Pharmacy

RWA Pharmacy’s Adele West-Curran highlights key facts about the current state of English pharmacies while exploring future opportunities…

As COO of a business intelligence solution catering to community pharmacy in England, I look at a lot of data, from all across the country. As a result, my interpretation of the industry differs slightly from others.

Like many of you, I have read multiple articles spouting doom and gloom for this industry. While there is no denying that! In fact, I’m not sure I have ever seen such a level of empowering media attention across the industry as I have throughout 2024. Strong voices from pharmacy associations are bringing awareness to the challenges being felt by community pharmacies.


The struggle being felt by pharmacies is real, however, after another year analysing pharmacy data, I have a reason for hope. I meet with many customers who are hitting challenges head on. They’re becoming data-driven, focusing on opportunities for improvements. Many are also investing in new technologies to lighten the load of their hard-working staff. The reality though is that the need to adapt will soon no longer be a choice. There are many reasons why the need to adapt is now so strong. Here is a breakdown of some of the facts about English pharmacies in 2024 which paints the scene:

Screenshot 2024 12 03 171530

Now let’s look at each of these in a little more detail:

Lower contracts / Increased closures

A reduction in the number of contracts means pharmacies are faced with a higher volume of patients and, as a result, higher dispensing item volumes. New opportunities bring new challenges. We know dispensing margins are falling, and there is a real pressure to drive more services from pharmacy to make up the difference. Staff in pharmacies are under pressure to deliver these services, on top of dispensing medicines. Pharmacy owners and managers are faced with issues like increased wage costs on one side and burnout on the other. From the data, typically we are seeing a 3% drop in dispensing in the last 24 months. With less dispensing margin to play with, everyone is trying to do more with less.

However, if a pharmacy can identify areas where they are losing money or processes that aren’t as efficient as they could be, they may be able to creep back some of the losses being felt.

Consolidations

There have been many high-profile consolidations throughout the last few years. One that comes to mind in particular is Lloyds who sold many branches off in 2023. Some of these were then closed and merged into other existing contracts which allowed investment into one branch rather than two. This also doubled the number of patients and scripts within those pharmacies.

The good news here is that we are seeing many pharmacies react to these challenges in new and innovative ways. To offset these pressures, many of these multiples have adapted and implemented forward thinking technologies, such as hub – dispensing and robots. Not only can tools like this save time, but they can also increase efficiency, reduce errors, and help with stock management. While the investment may be high, so too is the reward.

Divesting & Retirement Sales

Outside of the whole Llyod’s sale, we have seen some significant sales of some of the larger multiples.  Having access to data and insights about locality demographics, condition diversities, prescribing trends, margin vulnerabilities, and other aspects will have contributed to these decisions by the larger group owners.  This will be leading to new players in the market.

New pharmacy owners are establishing businesses in a different environment than those before them. They are aware of the demands set against community pharmacies and the reality of what it takes to deliver and so approach things differently.

It is up to the NHS to support this new generation of pharmacy owners, so they thrive and successfully maintain their businesses while also delivering the highest quality of patient care. The risk of burnout and bankruptcy is a real threat facing all owners.

Contract changes

The amount of contract changes throughout 2024 has been significant. While it may be flying under the radar for now, it is an early indication that pharmacy owners can’t afford to keep their pharmacies open. Many are moving to shorter hour contracts as a way to manage overheads and wages.

Community pharmacy is vital in England. Pharmacies are providing such a varied range of services and managing patient care to a very high standard. The reality of running a profit-making business continues to be very challenging for them. However, a growing number of pharmacies are adapting well to change. They are pivoting to new technologies and systems like dispensing robots or even data analytics to ensure their businesses run as efficiently and as smoothly as possible. The amount of data and information around the pharmacy industry has never been greater, enabling data-driven decision making and consistent results. I see this playing out in real life with our customers and feel hopeful for the future.

By Adele West-Curran, Chief Operating Officer, RWA Pharmacy

More For You

Why community pharmacy must embrace private services
The range of private services offered by pharmacists is likely to grow exponentially over the coming years (gettyimages)

Future of community pharmacy: Be more private

Tariq Muhammad considers how community pharmacy must explore private services to help create a more sustainable future.

We know remuneration influences behaviour. If I have a construction company and I pay a bricklayer a fee per brick to supply and fit, I suspect he will source them from the cheapest supplier and lay as many bricks as he possibly can. If one day, I reduce the fee such that it barely covers the cost of the brick, at a time when bricks are in short supply and labour costs have gone up, oh and I take some money off him for the profit he made on bricks he supplied the previous year, I suspect he will tell me to stick my job where the sun doesn’t shine.

It may be a crude analogy, but it is pretty much what’s happened in community pharmacy over the last 20 years. The remuneration we get for dispensing does not cover the cost of providing the service. The reimbursement for the drugs does not cover the cost of the drugs. In fact, we make a loss on many items given all the clawbacks and supply shortages. Wages have gone up. And then each year the government claws back profit they say we’ve made, apparently!

Keep ReadingShow less
The Government must fund the pharmacy sector sufficiently to secure it’s future.
Currently, the number of pharmacies operating in England is at an almost twenty year low. (gettyimages)

Pharmacy is under severe strain, time for the government to back those who put patients first

"The new contract in England has to provide the injection of cash the pharmacy sector desperately requires" 

By Jeremy Meader

Healthcare is one of the most crucial sectors in the UK accounting for over £290 billion, around 10% of the GDP for the entire country.

Despite this, however, many businesses operating in the healthcare sector are currently in favour of an urgent cash injection from the government. The figures make for sobering reading with over 65% of pharmacies operating at a loss and a bleak forecast that one in six might shut their doors for good within the next year.

Jeremy Meader Chief Wholesale Officer Bestway Healthcare

Jeremy Meader is the Chief Wholesale Officer of Bestway Healthcare, overseeing brands such as Lexon, Wardles, and Bestway Medhub. Jeremy has over 25 years of experience in the UK pharmaceutical sector, and has worked in executive roles across the industry.
Keep ReadingShow less
Harry McQuillan reflects on his first year as chairman of Numark UK
Harry McQuillan, Numark UK Chairman

Reflections on my first year as Numark UK chairman

The lack of a stable, predictable funding framework remains a critical issue for pharmacies in England - Harry McQuillan

As I reflect on my first year as chairman of Numark, I am struck by the incredible progress we’ve made together and the exciting opportunities that lie ahead for community pharmacy. This milestone feels like the perfect moment to take stock of our achievements and look forward to the future.

Stepping into this role after 17 years as a chief executive was both exhilarating and, I’ll admit, a little daunting. However, any initial apprehension quickly faded thanks to the warm welcome and support from my fellow UK Board members, the exceptional Numark team, and our dedicated members. It’s this shared sense of purpose, supporting our members to deliver outstanding care to their communities that continues to inspire me every day.

Keep ReadingShow less
collaboration in healthcare settings
collaboration in healthcare settings

Do you have to like each other to Collaborate?

By Trevor Gore, Associate Director, Institute for Collaborative Working (ICW)

May I be one of the last people to wish you a ‘Happy New Year’

The new year is traditionally a time to reflect on the year past and look forward to the new year and all the joys and challenges it will bring, possibly by making a resolution. However, the statistics do not bode well for your resolution lasting.

Keep ReadingShow less
Ministers must now urgently table the long trailed new deal for community pharmacy
Paul Rees Former NPA chief executive

Community pharmacy owners are ‘fed up’ with how they’re treated by the NHS

"Ministers must now urgently table the long trailed new deal for community pharmacy"

By Paul Rees, former chief executive of the National Pharmacy Association (NPA)

When former Health Secretary Matt Hancock gave evidence to the Covid public inquiry he let the cat out of the bag.

Keep ReadingShow less